Raily Aesmed (02135) announced its full-year financial results for the fiscal year ended December 31, 2025. The group recorded revenue of 189 million yuan, representing a decrease of 4.98% compared to the previous year. Profit attributable to shareholders was 1.87 million yuan, marking a turnaround from a loss in the same period last year. Earnings per share were 0.34 cents.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.